<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397406</url>
  </required_header>
  <id_info>
    <org_study_id>33447/10/19</org_study_id>
    <nct_id>NCT04397406</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor</brief_title>
  <official_title>Role of Dexmedetomidine or Fentanyl as Additives to Epidural Levobupivacaine in Painless Labor: A Double Blind Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central neuraxial analgesia has been extensively used for labor analgesia and is currently
      the gold standard technique for pain control in obstetrics.

      The aim of the study will be to compare the role of dexmedetomidine or fentanyl as additives
      to epidural levobupivacaine in painless vaginal delivery as regard maternal analgesia and
      safety.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomly allocated into three equal groups by computer generated sequence through sealed opaque envelopes. Each group will include 30 patients.
Group C (Control group): Epidural analgesia with levobupivacaine alone Group D (Dexmedetomidine group): Epidural analgesia with levobupivacaine and dexmedetomidine Group F (Fentanyl group): Epidural analgesia with levobupivacaine and fentanyl</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of maternal analgesia</measure>
    <time_frame>24 hours after epidural injection</time_frame>
    <description>Duration of analgesia will be assessed by measuring the time between the onset of sensory block and return of pain sensation. If the block is inadequate or the patient has pain, a top up dose of 8 mL of the study medication and local anesthetic will be given when visual analogue scale (VAS) will be ≥ 4.
The pain relief will be assessed by the visual analogue scale (VAS) from 0 to 10 (0: no pain, 1-3: mild pain, 4-7: moderate pain, &gt; 7: severe pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of maternal analgesia.</measure>
    <time_frame>One hour after epidural injection</time_frame>
    <description>The onset of analgesia will be defined as the time taken from drug administration to visual analogue scale (VAS) &lt;3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of drugs of epidural technique</measure>
    <time_frame>24 hours after epidural injection</time_frame>
    <description>Drugs: Sedation, Bradycardia Epidural anesthesia (including nausea, vomiting, backache and fever)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Epidural Analgesia</condition>
  <condition>Painless Labor</condition>
  <condition>Dexmedetomidine</condition>
  <condition>Fentanyl</condition>
  <condition>Levobupivacaine</condition>
  <arm_group>
    <arm_group_label>Group C (Control group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pidural analgesia with levobupivacaine alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D (Dexmedetomidine group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural analgesia with levobupivacaine and dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group F (Fentanyl group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural analgesia with levobupivacaine and fentanyl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>The patients will receive 15 ml of 0.125% levobupivacaine.</description>
    <arm_group_label>Group C (Control group)</arm_group_label>
    <arm_group_label>Group D (Dexmedetomidine group)</arm_group_label>
    <arm_group_label>Group F (Fentanyl group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>The patients will receive 13 ml of 0.125% levobupivacaine and 0.5μg/kg dexmedetomidine diluted in 2 ml saline.</description>
    <arm_group_label>Group D (Dexmedetomidine group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>The patients will receive 13 ml of 0.125% levobupivacaine and 25μg fentanyl diluted in 2 ml saline.</description>
    <arm_group_label>Group F (Fentanyl group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) physical status class II and III,

          -  Full term pregnancy.

        Exclusion Criteria:

          -  Patient refusal to epidural analgesia,

          -  Contraindications of epidural analgesia (coagulopathy, local infection, vertebral
             deformity hypersensitivity to levobupivacaine, dexmedetomidine or fentanyl,
             hemodynamic instability, severe aortic or mitral stenosis),

          -  Cardiac diseases

          -  Severe pre-eclampsia,

          -  Breech presentations

          -  Antepartum hemorrhage

          -  Cephalopelvic disproportion

          -  Body mass index ≥40 kg/m2.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hend Mahmoud El-shazly, MSc</last_name>
    <phone>00201064542053</phone>
    <email>hend.elshazly@med.tanta.edu.eg</email>
  </overall_contact>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Hend Mahmoud Moneeb El-shazly</investigator_full_name>
    <investigator_title>Assistant lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

